- 1.50 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.50 Hours of ParticipationHours of Participation credit.
The field of Pediatric Surgery is continuously advancing. Pediatric surgeons have to stay current in the methods of evaluation and techniques of surgery in order to provide best care for infants and children at a tertiary level and to teach residents and fellows. Additionally, the field of research in Pediatric health care must keep pace with current clinical developments. Ideally, this conference would bring together research and clinical concepts to achieve advances in patient care.
Continuing education is essential for staying current and up to date for all faculty and employees at the Medical College of Wisconsin and Children’s Hospital of Wisconsin. The fields of Surgery and basic research are advancing at an alarming rate. One of the best ways of staying current is to have focused studies of cutting edge research presented by experts in the field. Faculty and employees who attend our conferences will be better educated, understand the current state of the art and as a result be much more competent faculty and employees.
The main goal of this conference is to increase dialogue between clinical staff and bench researchers, and see an increased number of collaborations between these two groups.
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Medical College of Wisconsin designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Medical College of Wisconsin designates this activity for up to 1.5 hours of participation for continuing education for allied health professionals.
Pediatric Surgery faculty and staff
- Understand the mediators driving inflammation in sickle cell disease.
- Explain the receptors mediating inflammation in sickle cell disease.
- Discuss how to develop inhibitors to block inflammation in sickle cell disease.
Kirkwood Pritchard, Ph.D. (Activity Director)
Keith Oldham, MD (Planner)
Meghann Sytsma (Coordinator)
Kirkwood A. Pritchard, Jr, PhD
All persons in control of content have NO relevant financial relationships to disclose